MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s43441-025-00903-x

Медицинская библиотека · Therapeutic innovation & regulatory science · 2025

Patent Term Extension for Innovative Drugs in China: A Cohort Study from 2021 to 2024.

Yao Xuefang, Zhang Yan, Zhou Jin

СтатьяПеревод в очереди

Аннотация

BACKGROUND

In January 2024, China officially implemented the patent term extension (PTE) system, that is, began to implement PTE for innovative drugs approved after June 1, 2021. This study analyzed the PTE system's outcomes in China and its potential impact on drug accessibility.

METHODS

We conducted a simulation analysis of the PTE duration and effective patent life after listing (EPLL) of innovative drugs approved by Chinese regulatory authorities from June 2021 to December 2024, using data collected from public databases such as China's marketed drug patent registration platform.

RESULTS

A total of 148 innovative drugs were included in the study. Among them, 61% were able to obtain PTE, with a median PTE duration of 5 years (IQR: 2.3-5). The median EPLL before adding PTE was 9 years (IQR: 6.1-11.7), and the median EPLL after adding PTE was 14 years (IQR: 11.1-14), an increase of 55.6%. Furthermore, the study reveals variations across drug types and therapeutic areas.

CONCLUSIONS

Compared to findings from prior studies on the U.S. and the European Union, the median PTE duration for innovative drugs in China is longer, while the median EPLL is only marginally extended. Both Chinese domestic stakeholders and foreign enterprises should evaluate the potential impact by considering both the incremental PTE periods and the overall EPLL levels.

Для цитирования: Yao Xuefang, Zhang Yan, Zhou Jin. Patent Term Extension for Innovative Drugs in China: A Cohort Study from 2021 to 2024.. Therapeutic innovation & regulatory science. 2025. DOI: 10.1007/s43441-025-00903-x.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.